Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22291 AL 22305

Cholesterol-modifying strategies for Alzheimer disease: promise or fallacy?

Azarfar K, Decourt B, Sanchez Camacho B, Lawrence JJ, Omondi TR, Sabbagh MN.

Expert Rev Neurother. 2025 May;25(5):521-535. doi: 10.1080/14737175.2025.2483928. Epub 2025 Apr 3.

Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's disease

Ruthirakuhan M, Guan DX, Mortby M, Gatchel J, Babulal GM.

Alzheimers Dement. 2025 Mar;21(3):e70079. doi: 10.1002/alz.70079.

Inflammatory Bridges: Interconnections Between Alzheimer's Disease and Bone Health

Li H, Wang W, Zhang L, Wang T, Liu J, Wu J, Ni Q, Sun B, Sun J.

Aging Dis. 2025 Mar 19;17(2):927-981. doi: 10.14336/AD.2025.10319.

Cholinesterase-based inhibitors as multitarget small molecules for the therapy of Alzheimer's disease

Marco-Contelles JL, Oset-Gasque MJ.

Chem Biol Interact. 2025 May 25;413:111497. doi: 10.1016/j.cbi.2025.111497. Epub 2025 Mar 28.

New insight into the role of altered brain cholesterol metabolism in the pathogenesis of AD: A unifying cholesterol hypothesis and new therapeutic approach for AD

Yang X, Yao K, Zhang M, Zhang W, Zu H.

Brain Res Bull. 2025 May;224:111321. doi: 10.1016/j.brainresbull.2025.111321. Epub 2025 Mar 29.

Immune modulation to treat Alzheimer's disease

Duggan MR, Morgan DG, Price BR, Rajbanshi B, Martin-Peña A, Tansey MG, Walker KA.

Mol Neurodegener. 2025 Mar 31;20(1):39. doi: 10.1186/s13024-025-00828-x.

Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies

Kordi R, Andrews TJ, Hicar MD.

Virology. 2025 Jun;607:110523. doi: 10.1016/j.virol.2025.110523. Epub 2025 Mar 27.

Unraveling the cGAS-STING pathway in Alzheimer's disease: A new Frontier in neuroinflammation and therapeutic strategies

Kaur A, Aran KR.

Neuroscience. 2025 May 7;573:430-441. doi: 10.1016/j.neuroscience.2025.04.001. Epub 2025 Apr 2.

Internalization of extracellular Tau oligomers in Alzheimer's disease

Chinnathambi S, Rangappa N, Chandrashekar M.

Adv Clin Chem. 2025;126:1-29. doi: 10.1016/bs.acc.2025.01.005. Epub 2025 Feb 12.

Reducing Alzheimer's disease risk with SGLT2 inhibitors: From glycemic control to neuroprotection

Alami M, Morvaridzadeh M, El Khayari A, Boumezough K, El Fatimy R, Khalil A, Fulop T, Berrougui H.

Ageing Res Rev. 2025 Jun;108:102751. doi: 10.1016/j.arr.2025.102751. Epub 2025 Apr 7.

Microbial diversity and fitness in the gut-brain axis: influences on developmental risk for Alzheimer's disease

Jamerlan AM, An SSA, Hulme JP.

Gut Microbes. 2025 Dec;17(1):2486518. doi: 10.1080/19490976.2025.2486518. Epub 2025 Apr 10.

Unveiling the Protective Roles of Melatonin on Glial Cells in the Battle Against Alzheimer's Disease-Insights from In Vivo and In Vitro Studies

Sirimaharaj N, Thiankhaw K, Chattipakorn N, Chattipakorn SC.

Mol Neurobiol. 2025 Aug;62(8):10414-10426. doi: 10.1007/s12035-025-04904-7. Epub 2025 Apr 10.

Altered Clearance and Amyloid-Related Imaging Abnormalities

Cogswell PM, Burkett BJ, Johnson DR, Pillai JJ.

Neuroimaging Clin N Am. 2025 May;35(2):267-275. doi: 10.1016/j.nic.2024.12.002. Epub 2025 Feb 19.

The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

Divecha YA, Rampes S, Tromp S, Boyanova ST, Fleckney A, Fidanboylu M, Thomas SA.

Pharmacol Rev. 2025 May;77(3):100052. doi: 10.1016/j.pharmr.2025.100052. Epub 2025 Mar 13.

Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer's Disease

Saadh MJ, Muhammad FA, Alazzawi TS, Fahdil AA, Athab ZH, Tuxtayev J, Alsaikhan F, Farhood B.

Mol Neurobiol. 2025 Aug;62(8):10577-10613. doi: 10.1007/s12035-025-04833-5. Epub 2025 Apr 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias